Risk factor analysis and prediction model construction for severe adenovirus pneumonia in children

Yaowen Liang1, Jinhuan Wu2, Gang Chen3

  • 1The Second Hospital of Nanjing, Affiliated Hospital to Nanjing University of Chinese Medicine, Nanjing, China.

PubMed

Insights

This study identified key risk factors for severe adenovirus pneumonia in children, including neutrophils, D-dimer, fibrinogen degradation products, B cells, and lactate dehydrogenase. A new prediction model demonstrates strong clinical utility for early disease detection.

Area of Science:

  • Pediatric Infectious Diseases
  • Clinical Epidemiology
  • Biostatistics

Background:

  • Severe adenovirus pneumonia poses a significant mortality risk in children.
  • Limited research exists on predictive models for severe adenovirus pneumonia.
  • Risk prediction models are crucial for individualized patient management and early intervention.

Purpose of the Study:

  • To identify clinical risk factors associated with the progression to severe adenovirus pneumonia in children.
  • To develop and validate a predictive model for severe adenovirus pneumonia.
  • To evaluate the clinical applicability of the developed prediction model.

Main Methods:

  • Retrospective analysis of 699 children with adenovirus pneumonia hospitalized between January 2017 and March 2024.
  • Utilized Ridge regression and multiple logistic regression to identify risk factors from 44 variables.
  • Constructed and evaluated a prediction model for severe adenovirus pneumonia.

Main Results:

  • Neutrophils, D-dimer, fibrinogen degradation products, B cells, and lactate dehydrogenase were identified as significant risk factors.
  • The prediction model demonstrated strong predictive power with an area under the receiver operating characteristic curve of 0.974.
  • The Hosmer-Lemeshow test (P=0.547) indicated good model fit.

Conclusions:

  • The study successfully identified key clinical variables predicting severe adenovirus pneumonia in children.
  • A novel prediction model was developed, exhibiting significant clinical application value.
  • Early identification of at-risk children can facilitate timely and targeted treatment strategies.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
213
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
181
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
304
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124